MDX-010

ipilimumab · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MDX-010, covering 2010-04-26 to 2021-09-27. Get the full timeline:

Most recent: Clinical Trial Update: MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 2]